Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 340019-69-4, Cc-11050, 1z08g7438a, Cc11050, Cyclopropanecarboxamide, n-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-3-oxo-1h-isoindol-4-yl)-, Cyclopropanecarboxamide, n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-3-oxo-1h-isoindol-4-yl]-
Molecular Formula
C24H28N2O6S
Molecular Weight
472.6  g/mol
InChI Key
QDZOBXFRIVOQBR-LJQANCHMSA-N
FDA UNII
1Z08G7438A

DOVRAMILAST is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-3-oxo-1H-isoindol-4-yl]cyclopropanecarboxamide
2.1.2 InChI
InChI=1S/C24H28N2O6S/c1-4-32-21-12-16(10-11-20(21)31-2)19(14-33(3,29)30)26-13-17-6-5-7-18(22(17)24(26)28)25-23(27)15-8-9-15/h5-7,10-12,15,19H,4,8-9,13-14H2,1-3H3,(H,25,27)/t19-/m1/s1
2.1.3 InChI Key
QDZOBXFRIVOQBR-LJQANCHMSA-N
2.2 Other Identifiers
2.2.1 UNII
1Z08G7438A
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cc-11050

2.3.2 Depositor-Supplied Synonyms

1. 340019-69-4

2. Cc-11050

3. 1z08g7438a

4. Cc11050

5. Cyclopropanecarboxamide, N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-3-oxo-1h-isoindol-4-yl)-

6. Cyclopropanecarboxamide, N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-3-oxo-1h-isoindol-4-yl]-

7. Refchem:124078

8. Unii-1z08g7438a

9. N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxo-2,3-dihydro-1h-isoindol-4-yl)cyclopropanecarboxamide

10. N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-3-oxo-1h-isoindol-4-yl]cyclopropanecarboxamide

11. (s)-n-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxoisoindolin-4-yl)cyclopropanecarboxamide

12. Dovramilast [inn]

13. Schembl673303

14. Orb1686985

15. Chembl4297460

16. Schembl29366888

17. Schembl30701938

18. Gtpl13581

19. Amg-634

20. Qdzobxfrivoqbr-ljqanchmsa-n

21. Ex-a12042

22. Da-72891

23. Ms-28749

24. Hy-147263

25. Cs-0542404

26. H42759

27. Cyclopropyl-n-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl}carboxamide

28. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2- (methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol- 4-yl}cyclopropanecarboxamide

29. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}cyclopropanecarboxamide

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 472.6 g/mol
Molecular Formula C24H28N2O6S
XLogP32.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area110
Heavy Atom Count33
Formal Charge0
Complexity823
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Phosphodiesterase 4 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 4.